Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / TPTX - Turning Point Therapeutics names Kumar Srinivasan as chief business officer

TPTX - Turning Point Therapeutics names Kumar Srinivasan as chief business officer

Turning Point Therapeutics Inc.
Turning Point Therapeutics (TPTX) announces the appointment of Kumar Srinivasan as the company's executive vice president and chief business officer, effective June 1.Srinivasan has over 20 years of experience in pharmaceutical and biotechnology companies, and most recently as vice president and global head of business development for the BioPharmaceutical business unit of AstraZeneca.He will be responsible for corporate strategy and business development, including collaborations and alliances.

For further details see:

Turning Point Therapeutics names Kumar Srinivasan as chief business officer
Stock Information
Company Name: Turning Point Therapeutics Inc.
Stock Symbol: TPTX
Market: NYSE
Website: tptherapeutics.com
Menu
TPTX TPTX Quote TPTX Short TPTX News TPTX Articles TPTX Message Board
Get TPTX Alerts

News, Short Squeeze, Breakout and More Instantly...